Profile
Dr. Gianni Garotta is a Director at OncoNOx ApS.
He is on the Board of Directors at OncoNOx ApS.
Dr. Garotta was previously employed as Executive Advisor by Eporgen SpA, Head-Biology by Human Genome Sciences, Inc., Head-Lead Development & Extramural Research by Alfama - Investigação e Desenvolvimento Lda., a Principal by Fondazione Irccs Istituto Nazionale Dei Tumori, a Principal by Basel Institute for Immunology, a Principal by Hoffmann-La Roche, Inc., a Principal by Roche Corp., a Principal by The Wistar Institute, and VP-Academic Collaborations & Extramural Research by Serono SA.
He received his undergraduate degree from the University of Milan and a doctorate degree from the University of Milan.
Gianni Garotta active positions
Companies | Position | Start |
---|---|---|
OncoNOx ApS
OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark. | Founder | 01/01/2011 |
Natimab Therapeutics Srl
Natimab Therapeutics Srl BiotechnologyHealth Technology Natimab Therapeutics Srl operates as a biotechnology company. It specializes in the identification and early-stage clinical development of monoclonal antibodies (mAbs) for the treatment of infectious diseases. The company was founded by Gianni Garotta, Maurizio Denaro, Marianne Murphy and Gerritt Hagens in 2009 and is headquartered in Colleretto Giacosa, Italy. | Chief Executive Officer | 01/01/2009 |
Former positions of Gianni Garotta
Companies | Position | End |
---|---|---|
Fondazione Irccs Istituto Nazionale Dei Tumori | Corporate Officer/Principal | - |
Basel Institute for Immunology | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Corporate Officer/Principal | - |
Eporgen SpA | Corporate Officer/Principal | - |
Training of Gianni Garotta
University of Milan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 9 |
---|---|
Proterris (Portugal) - Investigação e Desenvolvimento
Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Proterris (Portugal) - Investigação e Desenvolvimento de Produtos Farmacêuticos, Sociedade Unipessoal Lda. develops Carbon Monoxide-Releasing Molecules (CORMs) for therepy. The company was founded by Carlos José Rodrigues Crispim Romão, Werner Ernest Hass, Nuno Manuel de Castro Santos Arante e Oliveira and Stan Kugell on January 4, 2002 and is headquartered in Oeiras, Portugal. | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Roche Corp. | |
OncoNOx ApS
OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
Eporgen SpA | Finance |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Health Technology |
Natimab Therapeutics Srl
Natimab Therapeutics Srl BiotechnologyHealth Technology Natimab Therapeutics Srl operates as a biotechnology company. It specializes in the identification and early-stage clinical development of monoclonal antibodies (mAbs) for the treatment of infectious diseases. The company was founded by Gianni Garotta, Maurizio Denaro, Marianne Murphy and Gerritt Hagens in 2009 and is headquartered in Colleretto Giacosa, Italy. | Health Technology |
- Stock Market
- Insiders
- Gianni Garotta